OTHR-13. Effectivity and toxicity of off-label treatment with Trametinib monotherapy or in combination with Dabrafenib in children with relapsed or refractory brain tumor

por Bregonje, S (Selena), de Vos-Kerkhof, E (Evelien), Engels, F K (Frederike), van Veelen, M L C (Marie-Lise), van der Lugt, J (Jasper)
Publicado 2022